From: LuQi Formula relieves ventricular remodeling through improvement of HIF-1α-mediated intestinal barrier integrity
Variables
Patients ( n = 17)
Age ( year)
≤ 50
3 ( 17.6%)
50–80
9 ( 52.9%)
≥ 80
5 ( 29.4%)
Gender
Male
13 ( 76.4%)
Female
4 ( 23.5%)
NYHA Grade
Grade II
9 (52.9%)
Grade III
5 (29.4%)
Grade IV
3 (17.6%)